TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC
- DOI
- 10.1016/j.mtbio.2026.103784
- Published
- 2026-12
- Container
- Materials Today Bio
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.mtbio.2026.103784,
title = {TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC},
author = {Xinyue Xu and Yuanyuan Gao and Ruifei Zhao and Yating Chen and Zihao Wang and Yaxin Li and Xuejian Wang and Pengfei Zhang},
year = {2026},
journal = {Materials Today Bio},
doi = {10.1016/j.mtbio.2026.103784},
url = {https://doi.org/10.1016/j.mtbio.2026.103784}
}RIS
TY - JOUR TI - TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC AU - Xinyue Xu AU - Yuanyuan Gao AU - Ruifei Zhao AU - Yating Chen AU - Zihao Wang AU - Yaxin Li AU - Xuejian Wang AU - Pengfei Zhang PY - 2026 JO - Materials Today Bio DO - 10.1016/j.mtbio.2026.103784 UR - https://doi.org/10.1016/j.mtbio.2026.103784 ER -
APA
Xu, X., Gao, Y., Zhao, R., Chen, Y., Wang, Z., Li, Y., Wang, X., & Zhang, P. (2026). TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2026.103784
Source records
- crossref · retrieved 2026-11-07T15:07:13.697Z